• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

银屑病患者的代谢综合征——一项观察性研究

Metabolic Syndrome in Psoriasis Patients-an Observational Study.

作者信息

Dascǎlu Rucsandra Cristina, Bǎrbulescu Andreea Lili, Dinescu Ştefan Cristian, Bițǎ Cristina Elena, Stoica Loredana Elena, Sandu Raluca Elena, Vreju Florentin Ananu

机构信息

PhD Student, University of Medicine and Pharmacy of Craiova, Romania.

Department of Pharmacology, University of Medicine and Pharmacy of Craiova, Romania.

出版信息

Curr Health Sci J. 2024 Apr-Jun;50(2):215-222. doi: 10.12865/CHSJ.50.02.06. Epub 2024 Jun 30.

DOI:10.12865/CHSJ.50.02.06
PMID:39371054
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11447491/
Abstract

Our observational study included on 54 patients with PsO, evaluated into the Dermatology Department of the Emergency County Hospital Craiova, Romania, between August 2023 and January 2024, and 40 controls. Our research proposed determining the prevalence of MetS in a cohort of PsO patients, and its relationship to subclinical atherosclerosis, evaluated by carotid ultrasound. Metabolic syndrome (MetS) was established according to National Cholesterol Education Program (NCP) Adult Treatment Panel (ATP) III criteria for MetS for 35 of the patients (64.81%) vs. 11 of the control group (27.5%), p=0.0003. An overview of each component of MetS depending on the diagnostic criteria for MetS showed that waist and total cholesterol exerted significant differences. Carotid ultrasound evaluation revealed an increased ITM, of over 0.9mm, for 19 (35.18%) or PsO patients, significantly increased compared to controls, as well as the presence of carotid plaques in significantly different percentages (37.03% PsO vs. 17.5% controls, p=0.001). We also noted that for patients with MetS, US examination displayed increased results for IMT compared to those without MetS. The prevalence of carotid atheroma plaque was augmented in patients with MetS and PsO. In our PsO group IMT exerted a positive inter-relation with: age, MetS, blood glucose, disease duration, and PASI. Important to note is that after multiple linear regression analysis, age and MetS were independent indicators of IMT (p=0.02 for age and p=0.001 for MetS). Our findings sustain a firm relationship between MetS and psoriasis and the major consequence of this observation is the inherent risk of cardiovascular events.

摘要

我们的观察性研究纳入了2023年8月至2024年1月期间在罗马尼亚克拉约瓦县急诊医院皮肤科就诊的54例银屑病关节炎(PsO)患者以及40例对照。我们的研究旨在确定PsO患者队列中代谢综合征(MetS)的患病率及其与通过颈动脉超声评估的亚临床动脉粥样硬化的关系。根据美国国家胆固醇教育计划(NCEP)成人治疗小组(ATP)III的MetS标准,35例患者(64.81%)被诊断为MetS,而对照组中有11例(27.5%),p = 0.0003。根据MetS诊断标准对MetS各组成部分的概述显示,腰围和总胆固醇存在显著差异。颈动脉超声评估显示,19例(35.18%)PsO患者的内膜中层厚度(IMT)增加超过0.9mm,与对照组相比显著增加,同时颈动脉斑块的存在比例也有显著差异(PsO组为37.03%,对照组为17.5%,p = 0.001)。我们还注意到,与无MetS的患者相比,有MetS的患者超声检查显示IMT结果更高。MetS和PsO患者中颈动脉粥样斑块的患病率增加。在我们的PsO组中,IMT与年龄、MetS、血糖、病程和银屑病面积和严重程度指数(PASI)呈正相关。需要注意的是,经过多元线性回归分析后,年龄和MetS是IMT的独立指标(年龄p = 0.02,MetS p = 0.001)。我们的研究结果证实了MetS与银屑病之间的紧密关系,这一观察结果的主要后果是存在心血管事件的内在风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52a5/11447491/da0221e481eb/CHSJ-50-02-215-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52a5/11447491/686af1a88aea/CHSJ-50-02-215-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52a5/11447491/da0221e481eb/CHSJ-50-02-215-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52a5/11447491/686af1a88aea/CHSJ-50-02-215-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52a5/11447491/da0221e481eb/CHSJ-50-02-215-fig2.jpg

相似文献

1
Metabolic Syndrome in Psoriasis Patients-an Observational Study.银屑病患者的代谢综合征——一项观察性研究
Curr Health Sci J. 2024 Apr-Jun;50(2):215-222. doi: 10.12865/CHSJ.50.02.06. Epub 2024 Jun 30.
2
The metabolic syndrome and progression of carotid atherosclerosis over 13 years. The Tromsø study.代谢综合征与颈动脉粥样硬化 13 年进展。特罗姆瑟研究。
Cardiovasc Diabetol. 2012 Jun 27;11:77. doi: 10.1186/1475-2840-11-77.
3
Association of metabolic syndrome with carotid atherosclerosis in the young North Indian population.北印度年轻人群中代谢综合征与颈动脉粥样硬化的关联。
Diabetes Metab Syndr. 2011 Jul-Sep;5(3):153-7. doi: 10.1016/j.dsx.2012.02.004. Epub 2012 Mar 28.
4
Subclinical Atherosclerosis in a Gout Cohort: Prevalence and Associations.痛风队列中的亚临床动脉粥样硬化:患病率及相关性
Curr Health Sci J. 2024 Apr-Jun;50(2):274-282. doi: 10.12865/CHSJ.50.02.13. Epub 2024 Jun 30.
5
Metabolic syndrome, endothelial injury, and subclinical atherosclerosis in patients with systemic lupus erythematosus.代谢综合征、内皮损伤与系统性红斑狼疮患者的亚临床动脉粥样硬化
Scand J Rheumatol. 2010;39(1):42-9. doi: 10.3109/03009740903046668.
6
The metabolic syndrome is a stronger risk factor for early carotid atherosclerosis in women than in men.代谢综合征是女性早期颈动脉粥样硬化比男性更强的危险因素。
Stroke. 2005 Jun;36(6):1212-7. doi: 10.1161/01.STR.0000166196.31227.91. Epub 2005 May 12.
7
High prevalence of metabolic syndrome in patients with ankylosing spondylitis.强直性脊柱炎患者中代谢综合征的高患病率。
Clin Rheumatol. 2007 May;26(5):710-4. doi: 10.1007/s10067-006-0380-5. Epub 2006 Aug 25.
8
Association between presence of the metabolic syndrome and its components with carotid intima-media thickness and carotid and femoral plaque area: a population study.代谢综合征及其组分与颈动脉内膜中层厚度及颈动脉和股动脉斑块面积的关系:一项人群研究。
Diabetol Metab Syndr. 2013 Aug 20;5:44. doi: 10.1186/1758-5996-5-44. eCollection 2013.
9
Metabolic syndrome showed significant relationship with carotid atherosclerosis.代谢综合征与颈动脉粥样硬化显著相关。
Heart Vessels. 2016 May;31(5):664-70. doi: 10.1007/s00380-015-0668-y. Epub 2015 Mar 26.
10
The metabolic syndrome in middle-aged men according to different definitions and related changes in carotid artery intima-media thickness (IMT) during 3 years of follow-up.根据不同定义的中年男性代谢综合征以及3年随访期间颈动脉内膜中层厚度(IMT)的相关变化
J Intern Med. 2005 Jul;258(1):28-37. doi: 10.1111/j.1365-2796.2005.01511.x.

引用本文的文献

1
Limonin alleviates imiquimod-induced psoriasis-like skin inflammation in mice model by downregulating inflammatory responses.柠檬苦素通过下调炎症反应减轻咪喹莫特诱导的小鼠银屑病样皮肤炎症。
Naunyn Schmiedebergs Arch Pharmacol. 2024 Dec 19. doi: 10.1007/s00210-024-03655-x.

本文引用的文献

1
Evaluation and treatment of metabolic syndrome and cardiovascular disease in adult patients with psoriasis.成年银屑病患者代谢综合征和心血管疾病的评估与治疗
Int J Dermatol. 2023 Dec;62(12):1437-1446. doi: 10.1111/ijd.16873. Epub 2023 Oct 16.
2
Global prevalence of metabolic syndrome in patients with psoriasis in the past two decades: current evidence.过去二十年中银屑病患者代谢综合征的全球患病率:当前证据。
J Eur Acad Dermatol Venereol. 2022 Nov;36(11):1969-1979. doi: 10.1111/jdv.18296. Epub 2022 Jun 16.
3
Psoriasis and metabolic syndrome: implications for the management and treatment of psoriasis.
银屑病与代谢综合征:对银屑病治疗与管理的启示。
J Eur Acad Dermatol Venereol. 2022 Jun;36(6):797-806. doi: 10.1111/jdv.18044. Epub 2022 Mar 14.
4
Changes in metabolic syndrome and risk of psoriasis: a nationwide population-based study.代谢综合征的变化与银屑病风险:一项全国性基于人群的研究。
Sci Rep. 2021 Dec 15;11(1):24043. doi: 10.1038/s41598-021-03174-2.
5
Carotid intima-media thickness in patients with psoriasis with and without metabolic syndrome.银屑病伴和不伴代谢综合征患者的颈动脉内膜中层厚度。
Arch Cardiol Mex. 2022 Jul 1;92(3):305-311. doi: 10.24875/ACM.21000106.
6
Metabolic Syndrome and Psoriasis: Mechanisms and Future Directions.代谢综合征与银屑病:机制及未来方向
Front Immunol. 2021 Jul 23;12:711060. doi: 10.3389/fimmu.2021.711060. eCollection 2021.
7
Psoriasis: Comorbidities.银屑病:共病。
J Dermatol. 2021 Jun;48(6):732-740. doi: 10.1111/1346-8138.15840. Epub 2021 Mar 25.
8
Psoriasis in Patients with Metabolic Syndrome or Type 2 Diabetes Mellitus: Treatment Challenges.代谢综合征或 2 型糖尿病患者的银屑病:治疗挑战。
Am J Clin Dermatol. 2021 May;22(3):293-300. doi: 10.1007/s40257-021-00590-y. Epub 2021 Feb 15.
9
Pathogenesis of psoriasis in the "omic" era. Part I. Epidemiology, clinical manifestation, immunological and neuroendocrine disturbances.“组学”时代银屑病的发病机制。第一部分。流行病学、临床表现、免疫及神经内分泌紊乱
Postepy Dermatol Alergol. 2020 Apr;37(2):135-153. doi: 10.5114/ada.2020.94832. Epub 2020 May 5.
10
Psoriasis and Metabolic Syndrome: Comorbidities and Environmental and Therapeutic Implications.银屑病与代谢综合征:合并症以及对环境和治疗的影响
Cureus. 2019 Dec 12;11(12):e6369. doi: 10.7759/cureus.6369.